Bassam Mattar

Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study

Barbara Burtness, Meredith A. Goldwasser, William A. Flood et al. · Journal of Clinical Oncology · 2005 · 883 citations

Medicine, Oncology, Pharmacology +17

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

Debra L. Barton, Edward J. Wos, Rui Qin et al. · Supportive Care in Cancer · 2010 · 251 citations · Full text

Medicine, Neurology, Oncology +12

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)

Aminah Jatoi, Howard L. Ritter, Amylou C. Dueck et al. · Lung Cancer · 2009 · 218 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA

Debra L. Barton, Gamini S. Soori, Brent A. Bauer et al. · Supportive Care in Cancer · 2009 · 216 citations

Medicine, Oncology, Pharmacology +7

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518

James C. Yao, Katherine A. Guthrie, César A. Moran et al. · Journal of Clinical Oncology · 2017 · 163 citations · Full text

Medicine, Oncology, Pharmacotherapy +14